Table 3 Effect of intervention on primary and secondary endpoints
Outcomes | 3-Day Routine Change Group (n = 177) | Clinically Indicated Change Group (n = 185) | RR (95% CI), PValue |
|---|---|---|---|
Primary: | Â | Â | Â |
IVD complications per patient, n (%) | 64 (36%) | 76 (41%) | RR 1.14 (0.88, 1.47), p = 0.39 |
IVD complications per 1000 IVD days | 66.0 (95% CI 49.8, 82.1) | 67.8 (95% CI 52.6, 83.1) | HR 1.03 (0.74, 1.43), p = 0.86 |
Secondary: | Â | Â | Â |
Phlebitis, n (%) | 12 (7%) | 18 (10%) | RR 1.44 (0.71, 2.89), p = 0.34 |
Infiltration, n (%) | 53 (30%) | 61 (33%) | RR 1.10 (0.81, 1.49), p = 0.57 |
Occlusion, n (%) | 5 (3%) | 4 (2%) | RR 0.77 (0.21, 2.80), p = 0.75 |
Accidental removal, n (%) | 11 (6%) | 16 (9%) | RR 1.39 (0.66, 2.92), p = 0.43 |
Local infection | 0 | 0 | - |
IVD-related BSI, n (%) | 0 | 0 | - |
IVD costs per patient, AUD$ mean (SD) | $55.42 ($35.26) | $43.35 ($26.78) | Mean difference $12.07 (95%CI $5.57, $18.56), p < 0.001 |